openPR Logo
Press release

Active Pharmaceutical Ingredient Market 2021 Overview, Opportunities And Challenges Forecast To 2027

08-27-2021 08:58 AM CET | Health & Medicine

Press release from: Fortune Business Insights Pvt. Ltd.

Active Pharmaceutical Ingredient Market 2021 Overview,

The global active pharmaceutical ingredients (API) market size is set to gain impetus from the rising implementation of strict norms and regulations in several countries regarding the production of high-quality API. It is further aiding in upsurging the overhead costs of in-house API manufacturing. Therefore, numerous pharmaceutical companies are focusing on outsourcing the manufacturing. This information is provided by Fortune Business Insights™ in a recent report, titled, “Active Pharmaceutical Ingredients (API) Market Size, Share & Industry Analysis, By Type (Generic API, and Branded API), By Synthesis (Biological API, and Synthetic API), and Regional Forecast, 2019-2026.” The report further mentions that the API market size stood at USD 164.20 billion in 2018 and is projected to reach USD 261.28 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/active-pharmaceutical-ingredient-api-market-102656

Leading Players operating in the Active Pharmaceutical Ingredient Market are:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

Aurobindo Pharma
Teva Pharmaceutical Industries Ltd.
Reddy’s Laboratories Ltd.
Mylan N.V.
AbbVie Inc.
Sun Pharmaceutical Industries Ltd.
Abbott
Biocon
Cipla Inc.
Amgen Inc.
Other key market players
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers & acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

Drivers & Restraints-

High Demand for Novel Drugs to Boost Growth

The Indian Brand Equity Foundation (IBEF) mentioned that during 2015 to 2020, the pharmaceutical industry of India is set to exhibit a considerable CAGR of 22.4%. As per one of our lead analysts, “The incidence of chronic diseases is surging at a fast pace worldwide backed by the rising geriatric population. Rapid urbanization, as well as increasing adoption of sedentary lifestyle would also contribute to the growth.” Apart from that, there is an alarming rise in the number of new cases of chronic diseases. It is therefore, skyrocketing the demand for state-of-the-art drugs. High demand for biosimilars and biologics would hence, propel the active pharmaceutical ingredient market growth in the coming years. However, changes in price policies in the developing nations may hamper growth.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Table of Content:

1 Active Pharmaceutical Ingredient Market Overview

1.1 Active Pharmaceutical Ingredient Product Overview

1.2 Active Pharmaceutical Ingredient Market Segment by Type

1.3 Global Active Pharmaceutical Ingredient Market Size by Type (2015-2027)

1.3.1 Global Active Pharmaceutical Ingredient Market Size Overview by Type (2015-2027)

1.3.2 Global Active Pharmaceutical Ingredient Historic Market Size Review by Type (2015-2021)

1.3.2.1 Global Active Pharmaceutical Ingredient Sales Market Share Breakdown by Type (2015-2027)

1.3.2.2 Global Active Pharmaceutical Ingredient Market Share Breakdown by Type (2015-2027)

1.3.2.3 Global Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2027)

1.3.3 Global Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2027)

1.3.3.1 Global Active Pharmaceutical Ingredient Sales Market Share Breakdown by Application (2021-2027)

1.3.3.2 Global Active Pharmaceutical Ingredient Revenue Market Share Breakdown by Application (2021-2027)

1.3.3.3 Global Active Pharmaceutical Ingredient Average Selling Price (ASP) by Application (2021-2027)

1.4 Key Regions Market Size Segment by Type (2015-2021)

1.4.1 North America Active Pharmaceutical Ingredient Sales Breakdown by Type (2015-2027)

1.4.2 Europe Active Pharmaceutical Ingredient Sales Breakdown by Type (2015-2027)

1.4.3 Asia-Pacific Active Pharmaceutical Ingredient Sales Breakdown by Type (2015-2027)

1.4.4 Latin America Active Pharmaceutical Ingredient Sales Breakdown by Type (2015-2027)

1.4.5 Middle East and Africa Active Pharmaceutical Ingredient Sales Breakdown by Type (2015-2027)

2 Global Active Pharmaceutical Ingredient Market Competition by Company

2.1 Global Top Players by Active Pharmaceutical Ingredient Sales (2015-2021)

2.2 Global Top Players by Active Pharmaceutical Ingredient Revenue (2015-2021)

2.3 Global Top Players Active Pharmaceutical Ingredient Average Selling Price (ASP) (2015-2021)

2.4 Global Top Company Active Pharmaceutical Ingredient Manufacturing Base Distribution, Sales Area, Product Type

2.5 Active Pharmaceutical Ingredient Market Competitive Situation and Trends

2.5.1 Active Pharmaceutical Ingredient Market Growth Rate (2015-2021)

2.5.2 Global 5 and 10 Largest Company by Active Pharmaceutical Ingredient Sales and Revenue in 2019

2.6 Global Top Company by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharmaceutical Ingredient as of 2019)

2.7 Date of Key Company Enter into Active Pharmaceutical Ingredient Market

2.8 Key Company Active Pharmaceutical Ingredient Product Offered

2.9 Mergers and Acquisitions, Expansion

3 Global Active Pharmaceutical Ingredient Status and Outlook by Region (2015-2027)

3.1 Global Active Pharmaceutical Ingredient Market Size and CAGR by Region: 2015 VS 2021 VS 2027

3.2 Global Active Pharmaceutical Ingredient Market Size Market Share by Region (2015-2021)

3.2.1 Global Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2021)

3.2.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2021)

3.2.3 Global Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2015-2021)

3.3 Global Active Pharmaceutical Ingredient Market Size Market Share by Region (2021-2027)

3.3.1 Global Active Pharmaceutical Ingredient Sales Market Share by Region (2021-2027)

3.3.2 Global Active Pharmaceutical Ingredient Revenue Market Share by Region (2021-2027)

3.3.3 Global Active Pharmaceutical Ingredient Sales, Revenue, Price and Gross Margin (2021-2027)

3.4 North America Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

3.4.1 North America Active Pharmaceutical Ingredient Revenue By Growth (2015-2027)

3.4.2 North America Active Pharmaceutical Ingredient Sales By Growth (2015-2027)

3.5 Asia-Pacific Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

3.5.1 Asia-Pacific Active Pharmaceutical Ingredient Revenue By Growth (2015-2027)

3.5.2 Asia-Pacific Active Pharmaceutical Ingredient Sales By Growth (2015-2027)

3.6 Europe Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

3.6.1 Europe Active Pharmaceutical Ingredient Revenue By Growth (2015-2027)

3.6.2 Europe Active Pharmaceutical Ingredient Sales By Growth (2015-2027)

3.7 Latin America Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

3.7.1 Latin America Active Pharmaceutical Ingredient Revenue By Growth (2015-2027)

3.7.2 Latin America Active Pharmaceutical Ingredient Sales By Growth (2015-2027)

3.8 Middle East and Africa Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

3.8.1 Middle East and Africa Active Pharmaceutical Ingredient Revenue By Growth (2015-2027)

3.8.2 Middle East and Africa Active Pharmaceutical Ingredient Sales By Growth (2015-2027)

4 Global Active Pharmaceutical Ingredient by Application

4.1 Active Pharmaceutical Ingredient Segment by Application

4.1.1 Residential

4.1.2 Commercial

4.2 Global Active Pharmaceutical Ingredient Sales by Application: 2015 VS 2021 VS 2027

4.3 Global Active Pharmaceutical Ingredient Historic Sales by Application (2015-2021)

4.4 Global Active Pharmaceutical Ingredient Forecasted Sales by Application (2021-2027)

4.5 Key Regions Active Pharmaceutical Ingredient Market Size by Application

4.5.1 North America Active Pharmaceutical Ingredient by Application

4.5.2 Europe Active Pharmaceutical Ingredient by Application

4.5.3 Asia-Pacific Active Pharmaceutical Ingredient by Application

4.5.4 Latin America Active Pharmaceutical Ingredient by Application

4.5.5 Middle East and Africa Active Pharmaceutical Ingredient by Application

5 North America Active Pharmaceutical Ingredient Market Size by Country (2015-2027)

5.1 North America Market Size Market Share by Country (2015-2021)

5.1.1 North America Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2021)

5.1.2 North America Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2021)

5.2 North America Market Size Market Share by Country (2021-2027)

5.2.1 North America Active Pharmaceutical Ingredient Sales Market Share by Country (2021-2027)

5.2.2 North America Active Pharmaceutical Ingredient Revenue Market Share by Country (2021-2027)

5.3 North America Market Size By Growth by Country

5.3.1 U.S. Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

5.3.2 Canada Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

6 Europe Active Pharmaceutical Ingredient Market Size by Country (2015-2027)

6.1 Europe Market Size Market Share by Country (2015-2021)

6.1.1 Europe Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2021)

6.1.2 Europe Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2021)

6.2 Europe Market Size Market Share by Country (2021-2027)

6.2.1 Europe Active Pharmaceutical Ingredient Sales Market Share by Country (2021-2027)

6.2.2 Europe Active Pharmaceutical Ingredient Revenue Market Share by Country (2021-2027)

6.3 Europe Market Size By Growth by Country

6.3.1 Germany Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

6.3.2 France Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

6.3.3 U.K. Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

6.3.4 Italy Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

6.3.5 Russia Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7 Asia-Pacific Active Pharmaceutical Ingredient Market Size by Country (2015-2027)

7.1 Asia-Pacific Market Size Market Share by Country (2015-2021)

7.1.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2021)

7.1.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2021)

7.2 Asia-Pacific Market Size Market Share by Country (2021-2027)

7.2.1 Asia-Pacific Active Pharmaceutical Ingredient Sales Market Share by Country (2021-2027)

7.2.2 Asia-Pacific Active Pharmaceutical Ingredient Revenue Market Share by Country (2021-2027)

7.3 Asia-Pacific Market Size By Growth by Country

7.3.1 China Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.2 Japan Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.3 South Korea Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.4 India Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.5 Australia Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.6 Taiwan Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.7 Indonesia Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.8 Thailand Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.9 Malaysia Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

7.3.10 Philippines Active Pharmaceutical Ingredient Market Size By Growth (2015-2027)

Continue…

Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/102656

Market Segmentation:

By Type

Generic API
Branded API
By Synthesis

Biological API
Synthetic API
By Geography

North America (U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
Rest of the World
Have Any Query? Ask Our Experts:https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/active-pharmaceutical-ingredient-api-market-102656

Reasons to Purchase this Report:

Comprehensive analysis of the Active Pharmaceutical Ingredient Market growth drivers, obstacles, opportunities, and other related challenges.
Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
Identifies market restraints and boosters.
Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:

What are the key technological and Active Pharmaceutical Ingredient Market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?
Why Choose Fortune Business Insights?
What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the Active Pharmaceutical Ingredient Market growth?

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Linkedin | Twitter | BLogs

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Active Pharmaceutical Ingredient Market 2021 Overview, Opportunities And Challenges Forecast To 2027 here

News-ID: 2370431 • Views: 187

More Releases from Fortune Business Insights Pvt. Ltd.

Key Companies Covered in the Connected Drug Delivery Devices Market Research Rep …
The global “connected drug delivery devices market size” is projected to reach USD 4,062.7 million by 2026, exhibiting a CAGR of 35.4% during the forecast period. However, the market size was USD 361.1 million in 2018. This information is published in a recent report by Fortune Business Insights™, titled, “Connected Drug Delivery Devices Market Size, Share & Industry Analysis, By Type (Injectable Devices and Inhalation Devices & Others) By Technology
Key Companies Covered in the Hip Replacement Market Research Report are Raw mate …
The global hip replacement market size will increase with the advent of robot-assisted surgical procedures worldwide. Fortune Business Insights™ in their recent report titled, “Hip Replacement Market Size, Share & Industry Analysis, By Procedure (Total Hip Replacement, Partial Hip Replacement, and Revision & Hip Resurfacing), By End User (Hospitals & Ambulatory Surgery Centers, Orthopedic Clinics, and Others) and Regional Forecast, 2019-2026”, provides a comprehensive analysis of the market and their
Key Companies Covered in the Gene Therapy Market Research Report are Novartis AG …
The global gene therapy market is set to gain momentum from the rising incidence of different types of cancer. The field of this therapy is undergoing several technological advancements that would help in treating cancer in those patients who are at high risks of getting affected by this disease through genetic mutations. Fortune Business Insights™ provided this information in a new report, titled, “Gene Therapy Market Size, Share & COVID-19
Medical Transcription Software Market Size and Detailed Analysis Focusing On Key …
The global medical transcription software market size will benefit from the growing penetration of technology and automation in several applications across the healthcare industry. According to a report published by Fortune Business Insights, titled “Medical Transcription Software Market Size, Share & Industry Analysis, By Deployment (Cloud/Web-based and Installed/On-Premises), By End User Facility (Hospitals, Diagnostic Centers, Clinics, and Others), By Type (Voice Capture and Voice Recognition), By End User (Radiologists, Surgeons,

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business